Evidence map›Paper›PMID 41263502›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2026

Commentary Paper on Cooling Flavors in Cigarette and Non-Cigarette Tobacco Products.

Maansi Bansal-Travers, Andrea C Villanti, Michelle K Page, Maciej L Goniewicz, Richard J O'Connor, Daniel P Giovenco, Suchitra Krishnan-Sarin, Krysten W Bold, Andrew J Barnes, Simani M Price

Abstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maansi Bansal-TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY.ORCID 0000-0002-7944-3570
Andrea C VillantiDepartment of Health Behavior, Society, and Policy, Rutgers School of Public Health, New Brunswick, NJ.ORCID 0000-0003-3104-966X
Michelle K PageDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY.ORCID 0000-0002-5962-8586
Maciej L GoniewiczDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY.ORCID 0000-0001-6748-3068
Richard J O'ConnorDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Daniel P GiovencoDepartment of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, NY.ORCID 0000-0001-6256-9612
Suchitra Krishnan-SarinDepartment of Psychiatry, Yale School of Medicine, New Haven, CT.
Krysten W BoldDepartment of Psychiatry, Yale School of Medicine, New Haven, CT.ORCID 0000-0002-8012-6118
Andrew J BarnesDepartment of Health Policy, Virginia Commonwealth University School of Public Health, Richmond, VA.ORCID 0000-0002-0357-3934
Simani M PriceWestat Inc., Rockville, MD.

Funding

Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) Project 2: Addictive Threshold of Nicotine and the Impact of SweetenersU54DA036151 · NIDA · YALE UNIVERSITY · PI LISA M FUCITO · 2018 to 2026
$41.6M
Leadership and Logistics CoreU54DA046060 · NIDA · WESTAT, INC. · PI Andrea M Stroup · 2018 to 2026
$28.1M
Project 4: Using a prospective cohort survey to test population-level predictions generated by Projects 1-3U54DA036105 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI FAGAN, PEBBLES · 2018 to 2022
$20.8M
WNY Center for Research on Flavored Tobacco Products (CRoFT)U54CA228110 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI OSSIP, DEBORAH J · 2018 to 2022
$19.8M
Tobacco Industry Marketing CoreU54CA229973 · NCI · UNIVERSITY OF PENNSYLVANIA · PI STRASSER, ANDREW A · 2018 to 2022
$18.8M
SUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7M
Rutgers Center of Excellence in Rapid Surveillance of TobaccoU01CA278695 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI CRISTINE D DELNEVO, Ollie Ganz · 2023 to 2026
$14.0M
Food and Drug Administration (FDA), Center for Tobacco Products (CTP) and the National Institutes of Health (NIH) U54CA228110 (MBT, MLG), U54DA046060 (SMP, MC), U54DA036151 (KWB, SKS), K12 DA000167 (KWB), U54DA036114 (ACV) and 2U54DA036105 (AB)NCI NIH HHS U01 CA278695NCI NIH HHS U54 CA228110NCI NIH HHS U54 CA229973NIDA NIH HHS K12 DA000167NIDA NIH HHS U54 DA036105NIDA NIH HHS U54 DA036151NIDA NIH HHS U54 DA046060
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41263502
PMCPMC13052509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.